Related Experiment Video
Updated: May 20, 2026
07:51
Development and Functionalization of Electrolyte-Gated Graphene Field-Effect Transistor for Biomarker Detection
Published on: February 1, 2022
Initial Development of Current Profound Applications of Relative Graphene Material (RGM)-Based Drug Delivery Systems
Nguyen Thanh Hoai Nam1,2,3, Nguyen Hung Vu1,2,3, Nguyen Minh Dat1,2,3
1VNU-HCM, Key Laboratory of Chemical Engineering and Petroleum Processing (Key CEPP Lab), Ho Chi Minh City University of Technology (HCMUT), 268 Ly Thuong Kiet Street, Dien Hong Ward, Ho Chi Minh City 70000, Vietnam.
Langmuir : the ACS Journal of Surfaces and Colloids
|May 18, 2026
Summary
Graphene-based drug delivery systems (RGM-based DDSs) offer high capacity and versatility in nanomedicine. This review details their mechanisms, applications, and future potential in smart drug delivery.
Area of Science:
- Nanomedicine
- Materials Science
- Pharmaceutical Sciences
Background:
- Graphene-based drug delivery systems (RGM-based DDSs) are vital in nanomedicine due to their large surface area and functionalization capabilities.
- These systems offer high drug loading capacity, making them attractive for therapeutic applications.
Purpose of the Study:
- To review the classification, generation, and mechanisms of RGM-based DDSs.
- To evaluate the advantages and disadvantages of carbon-based and RGM-based DDSs.
- To analyze recent case studies and the future potential of RGM-based DDSs in smart drug delivery.
Main Methods:
- Literature review focusing on RGM-based DDSs.
- Analysis of drug loading and release mechanisms.
- Evaluation of case studies and research achievements.
Main Results:
- RGM-based DDSs exhibit significant potential in drug delivery applications.
- Key aspects like biocompatibility, toxicity, and manufacturing sustainability are critical for development.
- Current research highlights both achievements and limitations of these nanocarriers.
Conclusions:
- RGM-based DDSs represent a promising research direction for advanced biomedicines.
- These nanocarriers provide a strong foundation for developing next-generation smart drug delivery materials.
- Further research into sustainability and safety is essential for clinical translation.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.